Hong Seng's healthcare arm HS Bio acquires two industrial properties

Hong Seng executive director and HS Bio director Christopher Chan

KUALA LUMPUR: Hong Seng Consolidated Bhd has proposed to acquire a 100% stake in Premiumway Development Sdn Bhd (PDSB) for RM1.09mil.

In a filing with Bursa Malaysia, Hong Seng said its unit Neogenix Laboratoire Sdn Bhd (Neogenix Lab) had entered into a shares sale agreement (SSA) with the Ong Kah Hoe and Ong Kim Chong @ Ong Hwee Choo to undertake the proposed acquisition of one million ordinary shares, or 100% equity interest in PDSB.